ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 40 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $13,000 | -53.6% | 52,591 | -10.0% | 0.00% | – |
Q1 2019 | $28,000 | -36.4% | 58,447 | -48.2% | 0.00% | – |
Q4 2018 | $44,000 | -48.2% | 112,813 | -1.8% | 0.00% | – |
Q3 2018 | $85,000 | +26.9% | 114,926 | +10.3% | 0.00% | – |
Q2 2018 | $67,000 | +76.3% | 104,186 | 0.0% | 0.00% | – |
Q1 2018 | $38,000 | – | 104,186 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 339,796 | $163,000 | 0.04% |
Malaga Cove Capital, LLC | 30,000 | $14,000 | 0.01% |
Summit X, LLC | 35,000 | $16,000 | 0.01% |
ARDSLEY ADVISORY PARTNERS LP | 75,000 | $36,000 | 0.01% |
INTRUST BANK NA | 40,000 | $19,000 | 0.01% |
Fosun International Ltd | 168,851 | $78,000 | 0.01% |
Truvestments Capital LLC | 11,648 | $6,000 | 0.01% |
DLD Asset Management, LP | 140,660 | $68,000 | 0.00% |
Hartford Financial Management Inc. | 18,000 | $9,000 | 0.00% |
SNS Financial Group, LLC | 26,000 | $12,000 | 0.00% |